Glen Harbor Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$14K Hold
896
﹤0.01% 1311
2019
Q2
$18K Hold
896
﹤0.01% 1301
2019
Q1
$16K Hold
896
﹤0.01% 1284
2018
Q4
$11K Buy
+896
New +$11K ﹤0.01% 1261